Get started
Author

Shailesh Chavan

Indatuximab Ravtansine (BT062) in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma: Clinical Activity in Patients Already Exposed to Lenalidomide and Bortezomib
2014 · Kevin R. Kelly, Asher Chanan-Khan, et al. · Blood · 43
Indatuximab Ravtansine (BT062) In Combination With Lenalidomide and Low-Dose Dexamethasone In Patients With Relapsed and/Or Refractory Multiple Myeloma: Clinical Activity In Len/Dex-Refractory Patients
2013 · Kevin R. Kelly, Asher Chanan-Khan, et al. · Blood · 30
Inhibitory activities of Ficus benghalensis bark against carbohydrate hydrolyzing enzymes - An in vitro study
2011 · Faiyaz Ahmed, Shailesh Chavan, et al. · Pharmacognosy Journal · 20
Broad neutralization of hepatitis C virus‐resistant variants by Civacir hepatitis C immunoglobulin
2016 · Rajiv G. Tawar, Laura Heydmann, et al. · Hepatology · 11
PDF
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
2023 · Colin Anderson-Smits, Mary E. Ritchey, et al. · Neurology and Therapy · 10
PDF
Long-Term Safety of Facilitated Subcutaneous Immunoglobulin Treatment in Pregnant Women with Primary Immunodeficiency Diseases: Results from a Registry Study
2022 · Michael Borte, Stefan Raffac, et al. · Immunotherapy · 5
Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices
2024 · Shailesh Chavan, Michael P. McRae, et al. · PLoS ONE · 2
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
2023 · J. Bradley Layton, Mary E. Ritchey, et al. · Neurology and Therapy · 2
PDF
Hepatitis C an Ayurvedic approach - A Case Study
2017 · Vidyadhar Balikai, Prashanth A. S., et al. · Journal of Ayurveda and Integrated Medical Sciences · 2
Patient and Treatment Characteristics of a Large US Sample of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) Therapy (4212)
2021 · Colin Anderson-Smits, J. Bradley Layton, et al. · Neurology · 1
Rationale and Design of a Phase 3b Study of the Long-Term Tolerability and Safety of HyQvia in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): ADVANCE-CIDP 3 (4331)
2020 · Shabbir Hasan, Kimberly Duff, et al. · Neurology · 1
Phase 3 Study of Facilitated Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Interim Analysis of Immunogenicity (4194)
2021 · Shabbir Hasan, Hakan Ay, et al. · Neurology
Patient and Treatment Characteristics of a Large US Sample of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) Therapy (4442)
2020 · Colin Anderson-Smits, J. Bradley Layton, et al. · Neurology
Works count: 13
Citation count: 127
H-index: 5
I10-index: 5
Year
Topic
Type